NCT03305588

Brief Summary

To determine the efficacy of frameless Virtual Cone Radiosurgical Thalamotomy for medically refractory tremor resulting from either Essential Tremor or Tremor-Dominant Parkinson's Disease with the Fahn-Tolosa-Marin Tremor Rating Scale (FTMTRS) in patients who are not candidates for deep brain stimulation (DBS).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Dec 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Dec 2017Sep 2026

First Submitted

Initial submission to the registry

October 4, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 10, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

December 5, 2017

Completed
7.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

March 9, 2026

Status Verified

March 1, 2026

Enrollment Period

7.8 years

First QC Date

October 4, 2017

Last Update Submit

March 5, 2026

Conditions

Keywords

essential tremor (ET)stereotactic radiosurgery (SRS)radiosurgery (RS)deep brain stimulation (DBS)Parkinson's Disease (PD)tremor-dominant Parkinson's disease (TDPD)

Outcome Measures

Primary Outcomes (1)

  • Overall tremor reduction proportion evaluated by the Fahn-Tolosa-Marin Tremor Rating Scale (FTMTRS)

    The Fahn-Tolosa-Marin Tremor Rating Scale evaluation will assess the severity of the patient's tremor and measure the impact on their activities of daily living.

    From Baseline up to 36 months following completion of radiosurgery

Secondary Outcomes (7)

  • Number of Participants with treatment-related adverse events

    From Baseline up to 36 months following completion of radiosurgery

  • Changes in resting-state functional MRI (fMRI) and diffusion tensor patterns associated with Radiosurgical thalamotomy

    From Baseline up to 36 months following completion of radiosurgery

  • Mean of Quality of Life Scores measured by SF-36 questionnaire

    From Baseline up to 36 months following completion of radiosurgery

  • Mean of Quality of Life Scores measured by PROMIS Upper Extremity Questionnaire

    From Baseline up to 36 months following completion of radiosurgery

  • Patient Satisfaction Scores

    3 Month Follow-Up Visit

  • +2 more secondary outcomes

Study Arms (1)

130 Gy Radiation & Unframed Virtual Cone

EXPERIMENTAL

130 Gy Virtual Cone Radiosurgery Unframed (Face Mask)

Device: Unframed Virtual Cone

Interventions

The patient will undergo stereotactic radiosurgery. Radiosurgery is a single non-surgical radiation treatment and will be done as an outpatient procedure. High-energy radiation will be delivered to a small, precise area of the patient's brain using a linear accelerator. A face mask (unframed) will be placed over the patient's face to keep their head from moving during the procedure. During the procedure, the study doctor will confirm the exact location that needs to be treated using x-rays and optical imaging cameras. The face mask will hold the patient's head to prevent it from moving and to focus the x-rays and aim them on a small area in the thalamus of the patient's brain. For most patients, the actual time on the radiosurgery treatment machine is 30 to 60 minutes. The face mask will be removed after the treatment.

130 Gy Radiation & Unframed Virtual Cone

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with medical refractory essential tremor or tremor-dominant Parkinson's disease that are not candidates for deep brain stimulation (DBS), either by medical/surgical co-morbidities or by choice.
  • Patients must have an ECOG status of 0, 1, or 2.
  • Patients must be at least 18 years of age.
  • All patients must be given written informed consent.

You may not qualify if:

  • Patients who have had prior radiosurgery or therapeutic brain radiation therapy.
  • Patients with medical contra-indications to MRI imaging (e.g. pacemaker).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center

Birmingham, Alabama, 35249, United States

Location

Related Publications (1)

  • Middlebrooks EH, Popple RA, Greco E, Okromelidze L, Walker HC, Lakhani DA, Anderson AR, Thomas EM, Deshpande HD, McCullough BA, Stover NP, Sung VW, Nicholas AP, Standaert DG, Yacoubian T, Dean MN, Roper JA, Grewal SS, Holland MT, Bentley JN, Guthrie BL, Bredel M. Connectomic Basis for Tremor Control in Stereotactic Radiosurgical Thalamotomy. AJNR Am J Neuroradiol. 2023 Feb;44(2):157-164. doi: 10.3174/ajnr.A7778. Epub 2023 Jan 26.

MeSH Terms

Conditions

Essential TremorParkinson Disease

Condition Hierarchy (Ancestors)

Movement DisordersCentral Nervous System DiseasesNervous System DiseasesParkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • John Fiveash, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 4, 2017

First Posted

October 10, 2017

Study Start

December 5, 2017

Primary Completion

October 1, 2025

Study Completion (Estimated)

September 1, 2026

Last Updated

March 9, 2026

Record last verified: 2026-03

Locations